Data / Form D filings / Reven Pharmaceuticals, Inc.
Reven Pharmaceuticals, Inc.: Form D filings
Reven Pharmaceuticals, Inc., a pharmaceuticals company in Sarasota, FL, filed 6 Form D notices with the SEC between 2013 and 2015. The latest, on February 18, 2015, reports $4.4 million sold of a $7 million offering to 48 investors.
Find out what Reven Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4411 BEE RIDGE ROAD, SUITE 285, Sarasota, FL, 34233
- Phone
- (941) 320-9271
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Florida
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1556231
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 18, 2015 | Amendment | $7,000,000 | $4,440,594 | $2,559,406 | 48 | Jan 8, 2014 | sec.gov |
| Feb 19, 2014 | New notice | $7,000,000 | $0 | $7,000,000 | 0 | Yet to occur | sec.gov |
| Jan 29, 2014 | Amendment | $2,000,000 | $1,833,055 | $166,945 | 36 | Feb 5, 2013 | sec.gov |
| Jun 5, 2013 | Amendment | $2,000,000 | $526,025 | $1,473,975 | 16 | Feb 5, 2013 | sec.gov |
| Mar 8, 2013 | New notice | $1,000,000 | $22,500 | $977,500 | 2 | Feb 5, 2013 | sec.gov |
| Jan 28, 2013 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter B. Lange | Executive Officer, Director | |
| Brian B. Denomme | Executive Officer, Director | |
| Michael A. Volk | Executive Officer | |
| Michael B. Handley | Executive Officer |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Feb 16, 2015 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Reven Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.